2-[4-(3-Chlorophenyl)piperazin-1-yl]-N-(2,3-dichlorophenyl)acetamide

Catalog No.: 
ACZTPW160
CAS No.: 
303091-18-1
Molecular Formula: 
C18H18Cl3N3O
Molecular Weight: 
398.72
2-[4-(3-Chlorophenyl)piperazin-1-yl]-N-(2,3-dichlorophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$101.00InquiryInquiry
1g90%$322.00InquiryInquiry
5g90%$1578.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-[4-(3-Chlorophenyl)piperazin-1-yl]-N-(2,3-dichlorophenyl)acetamide
IUPAC Name2-(4-(3-chlorophenyl)piperazin-1-yl)-N-(2,3-dichlorophenyl)acetamide
Molecular FormulaC18H18Cl3N3O
Molecular Weight398.72
SMILESO=C(NC1=CC=CC(Cl)=C1Cl)CN2CCN(C3=CC=CC(Cl)=C3)CC2
InChI KeyHJHFWCYIDSZRJE-UHFFFAOYSA-N
Synonym2-[4-(3-CHLOROPHENYL)PIPERAZINO]-N-(2,3-DICHLOROPHENYL)ACETAMIDE;2-[4-(3-chlorophenyl)piperazin-1-yl]-N-(2,3-dichlorophenyl)acetamide;1-Piperazineacetamide, 4-(3-chlorophenyl)-N-(2,3-dichlorophenyl)-
CAS No.303091-18-1

Synthetic Route by SureRoute

1. ACZTPW160 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZTPW160 route product structure diagram
    ACZTPW160303091-18-1
Inquiry

2. ACZTPW160 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZTPW160 route product structure diagram
    ACZTPW160303091-18-1
Inquiry

3. ACZTPW160 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZTPW160 route product structure diagram
    ACZTPW160303091-18-1
Inquiry

Comments (0)